Resultados da pesquisa - Javier Alcácer
- A mostrar 1 - 6 resultados de 6
-
1
Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to V... Por Obrador, Elena, Valles, Soraya L., Benlloch, María, Sirerol, J. Antoni, Pellicer, José A., Alcácer, Javier, Coronado, Javier Alcácer-F., Estrela, José M.
Publicado em 2014Text -
2
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transi... Por Lara Milián, Manuel Mata, Javier Alcácer, María Oliver-Ferrándiz, María Sancho‐Tello, José Javier Martı́n de Llano, Carlos Camps, José M. Galbis, Julián Carretero, Carmen Cardá
Publicado em 2020Artigo -
3
Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells <i>In Vivo</i>: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism Por María Benlloch, Elena Obrador, Soraya L. Vallés, María L. Rodríguez, J. Antoni Sirerol, Javier Alcácer, José A. Pellicer, Rosario Salvador‐Palmer, Concha Cerdá, Guillermo T. Sáez, José M. Estrela
Publicado em 2015Artigo -
4
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC Por Jeffrey H. Becker, Yandi Gao, Margaret Soucheray, Inés Pulido, Eiki Kikuchi, María L. Rodríguez, Rutu Gandhi, Aránzazu Lafuente-Sanchis, Miguel Aupí, Javier Alcácer Fernández-Coronado, Paloma Martín-Martorell, Antonio Cremades, José M. Galbis, Javier Alcácer, Camilla L. Christensen, Patricia Simms, Ashley Hess, Hajime Asahina, Michael Kahle, Fátima Al‐Shahrour, Jeffrey A. Borgia, Agustín Lahoz, Amelia Insa, Óscar Juan, Pasi A. Jänne, Kwok‐Kin Wong, Julián Carretero, Takeshi Shimamura
Publicado em 2019Artigo -
5
Endothelin-1-mediated Drug Resistance in EGFR-mutant NSCLC Por Pulido, Inés, Ollosi, Stephen, Aparisi, Salvador, Becker, Jeffrey H., Aliena-Valero, Alicia, Benet, Marta, Rodríguez, María L., López, Adrián, Tamayo-Torres, Eva, Chuliá-Peris, Lourdes, García-Cañaveras, Juan Carlos, Soucheray, Margaret, Dalheim, Annika V., Salom, Juan B., Qiu, Wei, Kaja, Simon, Fernández-Coronado, Javier Alcácer, Alandes, Sandra, Alcácer, Javier, Al-Shahrour, Fátima, Borgia, Jeffrey A., Juan, Oscar, Nishimura, Michael I., Lahoz, Agustín, Carretero, Julián, Shimamura, Takeshi
Publicado em 2020Text -
6
CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC. Por Becker, Jeffrey H., Gao, Yandi, Soucheray, Margaret, Pulido, Ines, Kikuchi, Eiki, Rodríguez, María L., Gandhi, Rutu, Lafuente-Sanchis, Aranzazu, Aupí, Miguel, Fernández-Coronado, Javier Alcácer, Martín-Martorell, Paloma, Cremades, Antonio, Galbis-Caravajal, José M., Alcácer, Javier, Christensen, Camilla L., Simms, Patricia, Hess, Ashley, Asahina, Hajime, Kahle, Michael P., Al-Shahrour, Fatima, Borgia, Jeffrey A., Lahoz, Agustín, Insa, Amelia, Juan, Oscar, Jänne, Pasi A., Wong, Kwok-Kin, Carretero, Julian, Shimamura, Takeshi
Publicado em 2019Text
Ferramentas de pesquisa:
Assuntos relacionados
Biology
Cancer research
Medicine
Biochemistry
Cancer
Chemistry
Internal medicine
Pharmacology
Receptor
A549 cell
Agonist
Antioxidant
Biotechnology
Cannabidiol
Cannabinoid
Cannabinoid receptor
Cannabinoid receptor type 2
Cannabis
Cell
Cell biology
Cell growth
Chemokine
Chemokine receptor
Corticosterone
EGFR inhibitors
Endocrinology
Enzyme
Epidermal growth factor receptor
Epithelial–mesenchymal transition
Genetics